---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-009381"
form_type: "8-K"
ticker: null
cik: "0001848861"
company_name: "Healthcare AI Acquisition Corp."
filed_at: "2023-12-28T23:59:59+00:00"
generated_at: "2026-06-07T06:30:09.275080+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Healthcare AI Acquisition Corp. announces board and CEO change effective Dec. 28, 2023

## Summary
- Jiande Chen appointed CEO and Chairman; Zikang Wu resigns as CEO and director.
- Xiaocheng Peng appointed permanent CFO and non-independent director.
- Four new directors appointed: Jiande Chen, Nat Y Chan, Stefan Dodov, Manuel C. Menendez III.
- Outgoing directors: Zikang Wu, Hao Tian, Yuerong Tan, Zixun Jin.
- Changes effective Dec. 28, 2023, following required 14f-1 waiting period.

## SEC filing metadata
- accession: 0001477932-23-009381
- form_type: 8-K
- cik: 0001848861
- company_name: Healthcare AI Acquisition Corp.
- filed_at: 2023-12-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/haia_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-009381
- JSON: https://secwatch.observer/filing/0001477932-23-009381.json
- Plain text: https://secwatch.observer/filing/0001477932-23-009381.txt

## Key facts
- Executive change
  Xiaocheng Peng was appointed as Chief Financial Officer at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Nat Y Chan was appointed as Director at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Yuerong Tan resigned as Director at Healthcare AI Acquisition Corp..
  - Action: resigned
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Jiande Chen was appointed as Chairman of the Board at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Chairman of the Board
  source text: Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Zikang Wu resigned as Chief Executive Officer at Healthcare AI Acquisition Corp..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Zikang Wu shall resign as chief executive officer, to be effective upon the expiration of all applicable waiting periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Hao Tian resigned as Director at Healthcare AI Acquisition Corp..
  - Action: resigned
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Stefan Dodov was appointed as Director at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Manuel C. Menendez III was appointed as Director at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Jiande Chen was appointed as Chief Executive Officer at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Zikang Wu resigned as Director at Healthcare AI Acquisition Corp..
  - Action: resigned
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Jiande Chen was appointed as Director at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Zixun Jin resigned as Director at Healthcare AI Acquisition Corp..
  - Action: resigned
  - Role: Director
  source text: The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the "New Directors") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the "Outgoing Directors").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm
- Executive change
  Xiaocheng Peng was appointed as Director at Healthcare AI Acquisition Corp..
  - Action: appointed
  - Role: Director
  source text: Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.